Common Symptom, Rare Etiology: A Case Metastatic Cancers of Unknown Primary Origin Presenting with Epistaxis and Gingival Bleeding
- 18 August 2021
- journal article
- research article
- Published by Acil Tip Uzmanlari Dernegi in Journal of Emergency Medicine Case Reports
- Vol. 12 (3) , 85-87
Abstract
Introduction Epistaxis and gingival bleeding are among the most common presentation to the emergency department for patients with thrombocytopenia. Here, we present a case who was admitted to the emergency department with thrombocytopenia and was diagnosed with metastatic cancer of unknown primary origin. Case A 26-year-old male patient was admitted to the emergency department with gingival bleeding and epistaxis. The body temperature was 38.3 °C. Petechial rash, ecchymosis or organomegaly was not detected on physical examination. Laboratory results revealed thrombocytopenia as 31x 10³ (159-388 x 10³/μL). Although hemoglobin and leukocyte counts were normal, no band or precursor cell was observed in the patient's peripheral blood smear. There was no history of weight loss, night sweats, arthritis, malar rash, photosensitivity, contact with ticks, animals, or a COVID-19 patient. Serological tests performed for infections such as HIV, EBV, HCV, Crimean-Congo hemorrhagic fever were negative. Bone marrow biopsy was performed due to the unexplained cytopenia, reported as "signet ring cell metastatic adenocarcinoma". Gastrointestinal system endoscopy was performed to detect primary cancer. A biopsy was taken from the antrum and corpus revealed gastritis. An FDG PET-CT was revealed heterogeneously pathologically increased FDG attitude in all axial and appendicular bones. Despite all the modalities of diagnosis, the origin was not found and the patient was transferred to the oncology department for treatment with a diagnosis of cancer of unknown origin with bone marrow infiltration. Conclusions Bone marrow metastases should be kept in mind in patients presenting with thrombocytopenia.Keywords
This publication has 13 references indexed in Scilit:
- The role of molecular profiling in the diagnosis and management of metastatic undifferentiated cancer of unknown primary✰Seminars in Diagnostic Pathology, 2021
- Cancer of Unknown Primary: A Review on Clinical Guidelines in the Development and Targeted Management of Patients with the Unknown Primary SiteCureus, 2019
- Development and Validation of a Prognostic Score to Predict Survival in Adult Patients With Solid Tumors and Bone Marrow MetastasesMedicine, 2015
- Management of thrombocytopeniaF1000Prime Reports, 2014
- Patterns of hospital admission with epistaxis for 26,725 patients over an 18-year period in Wales, UKThe Annals of The Royal College of Surgeons of England, 2012
- Carcinomas of an unknown primary origin—diagnosis and treatmentNature Reviews Clinical Oncology, 2011
- Unknown primary tumorsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2011
- Bone marrow metastasis in solid tumors: Clinical evaluation of 64 casesJournal of Clinical Oncology, 2005
- Solid tumour with initial presentation in the bone marrow—a clinicopathologic study of 25 adult casesHematological Oncology, 1993
- Tumors of unknown origin in the bone marrowArchives of internal medicine (1960), 1986